Comparative Safety and Efficacy Study of New Bifonazol Spray vs Terbinafine Solution vs Placebo

Exclusion Criteria

• •Clinical history suggestive of intolerance or allergies to one of the products or the ingredients of the products
• •Plantar tinea pedis ("Mocassin-type")
• •Onychomycosis of any toe
• •Previous treatment with a systemic antifungal within 6 months prior to screening
• •Previous treatment of feet with a topical antifungal within 4 weeks prior to screening
• •Previous treatment with a topical antifungal applied to other areas of the body than feet within 2 weeks prior to screening
• •Previous treatment of any topical medication applied to the feet within 2 weeks prior to screening